share_log

908 Devices Analyst Ratings

Benzinga Analyst Ratings ·  Nov 15, 2022 04:03
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
11/15/2022 100.32% SVB Leerink $30 → $25 Maintains Outperform
03/08/2022 140.38% SVB Leerink $40 → $30 Maintains Outperform
05/14/2021 420.83% SVB Leerink $70 → $65 Maintains Outperform
01/12/2021 420.83% Stifel → $65 Initiates Coverage On → Buy
01/12/2021 Cowen & Co. Initiates Coverage On → Outperform
01/12/2021 460.9% SVB Leerink → $70 Initiates Coverage On → Outperform

What is the target price for 908 Devices (MASS)?

The latest price target for 908 Devices (NASDAQ: MASS) was reported by SVB Leerink on November 15, 2022. The analyst firm set a price target for $25.00 expecting MASS to rise to within 12 months (a possible 100.32% upside). 2 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for 908 Devices (MASS)?

The latest analyst rating for 908 Devices (NASDAQ: MASS) was provided by SVB Leerink, and 908 Devices maintained their outperform rating.

When is the next analyst rating going to be posted or updated for 908 Devices (MASS)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of 908 Devices, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for 908 Devices was filed on November 15, 2022 so you should expect the next rating to be made available sometime around November 15, 2023.

Is the Analyst Rating 908 Devices (MASS) correct?

While ratings are subjective and will change, the latest 908 Devices (MASS) rating was a maintained with a price target of $30.00 to $25.00. The current price 908 Devices (MASS) is trading at is $12.48, which is out of the analyst's predicted range.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment